US Approves First Drug Developed To Prevent Chronic Migraines


IN THE END OF THE WEEK AND FIRST SUMMER IF HE NEXT FRIDAY BACK TO YOU AT THE DESK. ON THE HEALTHWATCH TONIGHT NEW HELP FOR THE MILLIONS WHO SUFFER WITH MIGRAINE HEADACHES HEALTH REPORTER STEPHANIE STAHL HAS THE NEW F.D.A. APPROVAL. YES, F.D.A. APPROVAL. THIS IS THE FIRST IN, A NEW CLASS OF LONG ACTING, DRUGS, DESIGN, SPECIFICALLY TO PREVENT MIGRAINES. 10 MILLION AMERICANS GET MIGRAINE HEADACHES FREQUENTLY, AND THEY ARE COMING IN THE PEOPLE IN THE 30’S MOSTLY WOMAN AND CANNULAS FOR SEVERAL HOURS OR EVEN DAYS. NOW, THEY WILL HAVE A NEW TREATMENT OPTION, A FIRST OF ITS KIND DRUG DESIGNED TO PREVENT MIGRAINES. IT IS SIGNIFICANT BECAUSE WE NEVER HAD ANY PREVENTIVE SPECIFICALLY DESIGNED FOR PATIENT WHOSE HAVE MIGRAINES. REPORTER: UNTIL NOW DRUGS USED TO PREVENT MIGRAINES WERE DESIGNED TO TREAT OTHER DISEASES THEY ARE NOT VERY EFFECTIVE AND CAUSE SERIOUS SIDE EFFECTS. WE HAVE ALWAYS USED MEDICINE FORESEE SURES OR FOR BLOOD PRESSURE OR ANTIDEPRESSANT TOSS HELP TREAT MIGRAINES. AT LEAST AS PREVENTIVE GO. REPORTER: NOW DRUG IS CALLED ACPRG BLOCKER AND WILL BE AVAILABLE AS ONCE MONTHLY SELF INJECTION. IT TELLS BRAIN TO TURN OFF MIGRAINE BY BLOCKING A MOLECULE THAT CAUSES HEADACHE. IS THERE HOPE ON THE HORIZON. WE’RE VERY OPTIMISTIC BUT WE’RE ALSO CAUTIOUSLY OPTIMISTIC. REPORTER: RESEARCH SHOWS PEOPLE WITH HEART TO TREAT MIGRAINES TOOK NEW DRUG REPORTED FEWER HEADACHES WITH MANY PATIENTS ACHIEVING A 50 PERCENT REDUCTION. REPORTED SIDE EFFECTS INCLUDE INJECTION SITE IRRITATION AND CONSTIPATION, THE DRUG WILL COST $69,000 PER YEAR WITHOUT INSURANCE. THREE OTHER SHOTS ARE EXPECT TO WIN APPROVAL BY NEXT YEAR, AND SEVERAL PILLS FOR PREVENTING MIGRAINES ARE ALSO, BEING TESTED RIGHT NOW. SO FINALLY THERE IS GOING TO

About the author

Leave a Reply

Your email address will not be published. Required fields are marked *